INHIBITOREN VON TTBK1

Patent europeic · EP4351574 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4351574
Numer da la dumonda
EP22821235
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-06-2022
Publitgà
17-04-2024
Concedì
04-03-2026
La protecziun finescha il pli tard
06-06-2042
Proxima taxa annuala scadenta
30-06-2026
Classas IPC
C07D 487/04 (2006.01)
A61P 25/28 (2006.01)
A61K 31/519 (2006.01)
Prioritad
US 202163197809 P 07.06.2021
Dumonda PCT
PCT/US2022/072793 07.06.2022
Publicaziun PCT
WO2022/261627 15.12.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 04-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.03.2026

Partidas

Possessur

The General Hospital Corporation

55 Fruit Street, Boston, Massachusetts 02114, US

Dana-Farber Cancer Institute, Inc.

450 Brookline Avenue, Boston, Massachusetts 02215, US

Inventur

HAGGARTY, Stephen John

Gloucester, MA 01930, US

DA SILVA, Maria Catarina Telo Baptista Lima

Revere, MA 02151, US

FERGUSON, Fleur Marcia

Boston, MA 02215-5450, US

GRAY, Nathaniel S.

Boston, MA 02215-5450, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.